Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2019 Dec 10;14(12):e0226086. doi: 10.1371/journal.pone.0226086

Psychometric properties of the Portuguese version of the National Eye Institute Visual Function Questionnaire-25

Ricardo Y Abe 1,*,#, Felipe A Medeiros 2,#, Milton Agrizzi Davi 1,#, Cecília Gonçalves 1,#, Matheus Bittencourt 1,#, Alicia Buffoni Roque 1,#, Júlia Boccato 1,#, Vital Paulino Costa 1,#, José Paulo Cabral Vasconcellos 1,#
Editor: Stefan Hoefer3
PMCID: PMC6903730  PMID: 31821363

Abstract

Background

To investigate the psychometric properties of the Brazilian Portuguese version of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) questionnaire in a group of patients with different eye diseases.

Methods

Cross-sectional study. All subjects completed the Portuguese version of the NEI VFQ-25 questionnaire. Another questionnaire containing a survey about clinical and demographics data was also applied. Rasch analysis was used to evaluate the psychometric properties of the NEI VFQ-25.

Results

The study included 104 patients with cataract, 65 with glaucoma and 83 with age macular degeneration. Mean age was 70.7 ± 9.9 years, with 143 female (56.7%) and 109 male patients (43.2%). Mean visual acuity was 0.47 and 1.17 logMAR in the better and worse eye, respectively. According to Rasch analysis, seven items were found to misfit. Those items belonged to the following subscales: general health, social function, mental health, ocular pain and role limitations. The principal component analysis of the residuals showed that 55.5% of the variance was explained by the principal component. Eight items loaded positively onto the first contrast with a correlation higher than 0.4. These items belonged to the following subscales: near vision, distance vision, mental health and dependency. After excluding those items, we were able to isolate items from the NEI VFQ-25, related only to a visual functioning component. Finally, the principal component analysis from residuals of this revised version of the NEI VFQ-25 (items related to visual function) showed that the principal component explained 61.2% of the variance, showing no evidence of multidimensionality.

Conclusions

The Portuguese version of the NEI VFQ-25 is not a unidimensional instrument. We were able to find items that belong to a different trait, possible related to a socio-emotional component. Thus, in order to obtain psychometrically valid constructs, both the visual functioning and socio-emotional components should be analyzed separately.

Introduction

Quality of life (QoL) is a broad-ranging concept affected by an individual’s physical health, psychological state, level of independence and social relationships.[1, 2] Within physical health, sense of sight is crucial to perform many routine daily activities. Therefore, changes in visual status can lead to functional impairment affecting directly QoL. Conventional clinical measures such as visual acuity, visual field assessment and fundus imaging may not fully capture the impact of disability related to eye diseases. Thus measurements of health-related QoL have been used to track outcomes for many eye diseases.[3, 4] Even though many so-called health-related QoL questionnaires can measure only a self-perceived health status, the importance of evaluating the outcomes of health care from the standpoint of the patient is now widely recognized.[5, 6]

Within patient-reported questionnaires, the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) has been frequently used to assess QoL in ophthalmology research.[710] This questionnaire contains a set of 25 questions in 12 subscales designed to assess the dimensions of self-reported vision-target health status that are relevant for subjects with chronic eye diseases.[7] Items in the questionnaire require the subject to provide a response based on a Likert scale and methods for analyzing this type of data used in most previous studies attribute linear scores to each response and then sum up the scores for all different questions to obtain a single composite score. However, in order for a composite score to be meaningful is essential that all questions included in the scoring contribute to the measurement of a single underlying construct.[3, 11] For example, for the NEI VFQ-25 responses to be represented by a single score, its questions should all be measuring the same latent construct of visual functioning.

Rasch analysis is a method that can be used to investigate psychometric properties of questionnaires, such as dimensionality and reliability. Massof et al administered some items from the 52-NEI-VFQ to patients with low vision, applying Rasch model to estimate interval measurement scales from ordinal responses to items.[11] They found that Rasch analysis can offer an alternative to traditional scoring methods enabling one to estimate the latent variable of interest (visual function) and assess the performance of each item as a contributor to the final measurement. In a subsequent work, Marella and colleagues have suggested that the NEI VFQ-25 questionnaire does not seem to be unidimensional, and that the questionnaire items may actually be measuring two different underlying constructs, one related to visual functioning and another to socio-emotional status. This is important, as it would indicate that a single composite score is not appropriate to represent responses to this questionnaire. [12, 13] In addition to dimensionality, Rasch analysis can provide information about appropriateness of the response categories, measurement precision, and item fit to the construct.[14] Rasch analysis of the English version of the NEI VFQ-25 has also suggested that the subscales represented on the questionnaire would not be valid in their current format.[15]

As a widely used instrument to assess vision-related QoL, the NEI VFQ-25 has been translated into several different languages. When a questionnaire is translated into a new language, a linguistic validation is necessary but not sufficient unless the psychometric characteristics have been verified. Simao et al. introduced the Brazilian Portuguese version of the NEI VFQ-25 in 2008 and reported psychometrics properties comparable to the American original version.[16] However, the work of Simao et al reported only measures such as Cronbach’s alpha and correlations among subscales. The reason Rasch analysis is well suited for demonstrating a translated version of an existing questionnaire has comparable items to the original is its sensitivity to differences in item difficulty.[17] Cronbach’s alpha, for example, is insensitive to this, and can provide the same value for two questionnaires whose items differ in levels of difficulty. Thus, a proper validation of the Portuguese translation of the questionnaire would also benefit from a method such as Rasch analysis to better assess dimensionality and validity. To the best of our knowledge no study has yet applied the Rasch Analysis to the Portuguese version of the NEI VFQ-25 questionnaire. Thus, the purpose of current study is to investigate the psychometric properties of NEI VFQ-25 using Rasch analysis in a population of Brazilian patients with a variety of eye diseases.

Materials and methods

This was a cross sectional study, evaluating patients with glaucoma, cataract and age-related macular degeneration (AMD) from the Hospital das Clínicas–University of Campinas–Brazil. This study was approved by the Ethics Committee of the University of Campinas and adhered to the tenets of the Declaration of Helsinki. Subjects underwent a comprehensive ophthalmic examination, including Snellen best corrected visual acuity, slit-lamp biomicroscopy, intraocular pressure (IOP) measurement using Goldmann applanation tonometry, gonioscopy and dilated fundoscopy examination using a 78-diopter lens. Subjects underwent standard automated perimetry, using the 24–2 Swedish Interactive Threshold Algorithm (SITA) Standard (Humphrey, Carl Zeiss Meditec, Inc., Dublin, CA, USA) and also retinal imaging with nonmyd WX3D (Kowa, Japan).

Three different groups were investigated. Glaucoma patients were required to have repeatable (at least 2 consecutive) abnormal SAP results with corresponding glaucomatous optic nerve damage in at least one eye. An abnormal SAP result was defined as a pattern standard deviation with P < 0.05, and/or Glaucoma Hemifield Test results outside normal limits. Cataracts were classified according to the Lens Opacities Classification System III (LOCS III) based on findings from slit lamp examination.[18] For AMD, we applied the Clinical Age-Related Maculopathy Staging system, which divides patients into 5 mutually exclusive categories based on slit-lamp assessment of drusen, retinal pigment epithelial irregularities, geographic atrophy, retinal pigment epithelial detachment, and choroidal neovascularization.[19, 20]

NEI VFQ-25 Questionnaire

Vision-related QoL was assessed by a Brazilian Portuguese version of the NEI VFQ-25 questionnaire.[7] This version was developed by Simao et al in 2008 and was initially tested for in a set of ophthalmic patients and healthy controls.[16] The NEI VFQ-25 consists of 25 questions measuring overall vision, difficulty with near-vision and distance activities, ocular pain, driving difficulties, limitations with peripheral vision and color vision, social functioning, role limitations, dependency and mental health symptoms. Rasch analysis was performed to obtain final estimates of “person measures,” which can be used to express where each respondent falls on a linear scale representing the degree of impairment as measured by the NEI VFQ-25.[21, 22] Rasch analysis was performed using Andrich rating-scale models to obtain the estimates of the required ability of each item, perceived ability of each subject, and the thresholds for each response category.[14] The unit of those estimated measures is called a logit (log‐odds unit), which is calculated as the log‐odds ratio of the probability that a participant will select a particular rating category in an item over 1 minus the same probability. The logit values place patients according to their abilities and items according to their difficulties on the same linear interval scale. [23]

Person and item measures were examined for fit to the Rasch model using infit and outfit item fit statistics.[8] To test the hypothesis that the NEI VFQ- 25 measures a single underlying construct, we initially evaluated the fit statistics, which were recorded as mean square standardized residuals (MNSQ); The fit of the Rasch model was evaluated with the infit and outfit statistics. Values between 0.7 and 1.3 are considered acceptable for MNSQ values of infit and outfit.[24] After checking fit statistics, we conducted a principal components analysis of the residuals (difference between the observed and expected responses).[25] Data are considered unidimensional if most of the variance is explained by the principal component and there is no significant explanation of the residual variance by the contrasts to the principal component. In general, to be considered unidimensional, the variance of the principal component should be >60%.[8, 25] Furthermore, the unexplained variance by the contrasts should be <2 Eingenvalue units.[25]

We also evaluated differential item functioning, which assesses whether the items have different meanings for different groups in the sample. The raw differences in item calibration between groups were examined to identify differential item functioning. The differential item functioning was considered absent if it was less than 0.50 logits, minimal but probably inconsequential if it ranged between 0.50 and 1.0 logits, and notable if it was >1.0 logit.[12, 26]

The person separation index is the ratio of the variance in the person measures for the sample to the average error in estimating these measures. It is a measure of how broadly the persons could be distinguished into statistically distinct levels. The person separation reliability coefficient describes the reliability of the scale to discriminate between the persons of different abilities.[12] A person separation index of ≥ 2.0 or a reliability value of ≥ 0.8 represents the minimum acceptable level of separation.[12, 24]

Demographic, clinical and socio-economic variables

Socio-economic questionnaires were also administered along with the NEI VFQ-25 to all patients. These questionnaires contained a survey about demographics, history of ocular and medical conditions, marital status, degree of education and income. For comorbidities, we investigated the presence or history of the following conditions: diabetes mellitus, arthritis, high blood pressure, heart disease, depression, asthma, and cancers. A simple summation score was used to create a comorbidity index.[27] As these variables could potentially affect patient perceptions about vision-related QOL, they were included as covariates factors to investigate their association with the final Rasch-calibrated NEI VFQ-25 scores. These variables were categorized for inclusion in the univariate and multivariate models as race (African American [yes/no]), employment (yes/no), marital status (married [yes/no]), degree of education (at least high school degree [yes/no]) and income (less than $25,000/year [yes/no]). Visual acuity was measured using an Early Treatment Diabetic Retinopathy (ETDRS) chart and logMAR measurements were used in the analyses evaluating better and worse eye.[28] For patients with visual acuity measures of “counting fingers” (CF), “hand motion”, “light perception” and “no light perception” (NLP), we converted into quantitative measurements such as logMAR, as suggested by Schulze-Bonsel. [28]

Statistical analysis

Descriptive statistics included mean and standard deviation for normally distributed variables. We investigated the relationship between final Rasch-calibrated NEI VFQ-25 scores with socioeconomic and clinical variables (gender, race, education, income, marital status, visual acuity in logMAR, presence of low vision and mean deviation from standard automated perimetry) using a linear regression model. Variables with P value < 0.2 were included in the final multivariable linear regression model. Statistical analyses were performed using Winsteps 3.81.0 (Chicago, IL) and STATA v. 13 (StataCorp, College Station, TX). The alpha level (type I error) was set at 0.05.

Results

The study included 104 patients with cataract, 65 with glaucoma and 83 with AMD. Table 1 presents demographic variables of the studied population. Mean age was 70.7 ± 9.9 years, with 143 female (56.7%) and 109 male patients (43.2%). Most of them were retired (74%). Table 2 describes the clinical variables of the patients. Mean visual acuity in the better eye was 0.47 logMAR and 1.17 logMAR in worse eye. There were 62 patients (24.6%) with low vision (counting fingers, hand motion, light perception or loss of light perception in one or both eyes).

Table 1. Demographic characteristics of all patients included in the study.

Parameters Total subjects (n = 252)
Age (years)
    Mean ± SD 70.7± 9.9
    Range 30 to 103
Gender, n (%)
    Male 109 (43.2%)
    Female 143 (56.7%)
Race, n (%)
    Caucasian 204 (81.2%)
    African-American 44 (17.5%)
Job status (%)
    Employed 44 (18.1%)
    Unnenployed 19 (7.8%)
    Retired 180 (74.0%)
Marital status (%)
    Married 119 (69.5%)
    Single 25 (14.6%)
    Widowed 14 (8.1%)
    Divorced 13 (7.6%)
Education (%)
    Illiterate 2 (0.8%)
    Elementary school 137 (56.6%)
    High school degree 58 (23.9%)
    College degree 8 (3.2%)
Income per month (%)
    Lower than US$414.00 81 (48.2%)
    Between US$414.00 and US$2,073.00 68 (40.4%)
    Between US$2,073.00 and US$4,147.00 17 (10.1%)
    Higher than US$4,147.00 2 (1.1%)
Comorbidity Index (%)
    Zero 71 (28.9%)
    One 109 (44.4%)
    Two 58 (23.6%)
    Three 6 (2.4%)

Table 2. Clinical characteristics of all patients included in the study.

Parameters Total subjects (n = 252)
LogMar Visual acuity (better eye)
    Mean ± SD 0.47 ± 0.39
LogMar Visual acuity (worse eye)
    Mean ± SD 1.17 ± 0.74
SAP MD from glaucoma (better eye) (dB)
    Mean ± SD -4.26 ± 3.85
SAP MD OS from glaucoma (worse eye) (dB)
    Mean ± SD -10.77 ± 9.38
Low vision, n (%) 62 (24.6%)

SD: standard deviation; SAP: standard automated perimetry; MD: mean deviation; OD: right eye; OS: left eye.

Rasch analysis

Results of Rasch analysis are shown in Table 3. Five items (Q4, Q11, Q17, Q19 and Q25) were found to misfit (from subscales: social function, mental health, ocular pain and role limitations) with infit and/or outfit mean scores >1.3 and <0.7 (S1 Fig) Principal components analyses of the residuals from Rasch analysis can also be used to check the assumption of unidimensionality.[29] In order to determine whether the assumption of unidimensionality is valid, the variance explained by the Rasch factor (the underlying construct) should be 4 times greater than that of the first principal component in the residuals and the variance explained by the Rasch factor should be greater than 60%.[30]

Table 3. Fit Statistics using Rasch Analysis with respective Items and Subscales from National Eye Institute Visual Function Questionnaire (NEI VFQ-25).

Questions Items Subscales Measure Infit MNSQ Outfit MNSQ
Q1 General health General health 0.03 0.98 1.28
Q2 General vision General vision 0.02 0.62 0.77
Q3 Worry about eyesight Mental health 0.05 1.20 1.24
Q4 Pain around eyes Ocular pain -0.02 1.58 2.03
Q5 Reading normal newsprint Near vision 0.03 0.93 0.93
Q6 Seeing well up close Near vision 0.01 0.88 0.83
Q7 Finding objects on crowded shelf Near vision -0.01 0.79 0.73
Q8 Street signs Distance vision 0.01 0.91 0.92
Q9 Going downstairs at night Distance vision 0.00 0.79 0.75
Q10 Seeing objects off to side Peripheral vision -0.01 0.72 0.71
Q11 Seeing how people react Social function -0.04 0.90 0.61
Q12 Matching clothes Color vision -0.04 0.85 0.84
Q13 Visiting others Social function -0.02 1.07 0.87
Q14 Going out to movies/plays Distance vision 0.00 1.19 1.24
Q17 Accomplish less Role limitations 0.01 1.40 1.41
Q18 Limited endurance Role limitations 0.01 0.88 0.83
Q19 Amount of time in pain Ocular pain 0.00 1.65 1.75
Q20 Stay home most of the time Dependency -0.01 0.89 0.83
Q21 Frustrated Mental health 0.01 1.06 1.02
Q22 No control Mental health 0.00 1.01 0.92
Q23 Rely too much on others’ words Dependency -0.02 1.07 0.87
Q24 Need much help from others Dependency -0.01 0.96 0.87
Q25 Embarrassment Mental health -0.02 1.30 0.99

MNSQ: mean square

For the current work, the principal component analysis of the residuals showed that the variance explained by the principal component was comparable for empirical calculation (55.5%) and by the model (56.1%) (S2 Fig). This suggests that the questionnaire was not unidimensional. Moreover, the unexplained variance explained by the first contrast was 2.81 eigenvalue units and the second contrast was 2.04 eigenvalue units with no further contrasts exceeding 2.0 eigenvalue units. These findings suggested the presence of a second dimension in the scale. Eight items loaded (correlation>0.4) positively onto the first contrast and belonged to: near vision (Q5), distance vision (Q8 and Q14), mental health (Q21and Q22) and dependency (Q20, Q23 and Q24) (S3 Fig). This suggests that these eight items cannot be grouped with other items in the scale to measure a single latent trait (visual functioning). These items are probably related to a secondary component (probably, a social-emotional component). Of note, in the current sample, 187 patients (74.4%) answered that they were not currently driving (Q15). Within this group, 158 patients (84.5%) reported that they never had driven (Q15a). Therefore questions related to driving were not assessed in the Rasch Analysis due to missing data.

Differential item functioning was tested for some of the variables from Table 1 and Table 2, such as: age, gender, race, job status, marital status, education, level of income, low vision and type of eye disease (cataract, glaucoma and AMD). There was no differential item functioning for any of the variables mentioned. These results suggest that items could be interpreted similarly across subgroups of the sample.

After excluding items that were considered misfitted (Q4, Q11, Q17, Q19 and Q25) and also those items with high loadings on the principal component analysis of the residuals, such as: near vision (Q5), distance vision (Q8 and Q14), mental health (Q21and Q22) and dependency (Q20, Q23 and Q24), we were able to isolate items from the NEI VFQ-25, related only to the first component (probably, a visual function component). After running new analysis with items related visual function, we found that items Q1 and Q3 had values for infit and out fit >1.3 (S4 Fig). After excluding those items, we performed new Rasch Analysis and according to Table 4, no items were misfitted. We also performed a principal component analysis of the residuals of the revised version of the NEI VFQ-25 (items related to visual function and socio-emotional component). The final variance of the principal component was 61.2% and the unexplained variance by the contrasts is 1.49 eingenvalue units, showing no evidence of multidimensionality (Table 5). The mean (± SD) of the person measures was 0.05 ± 0.02 logits. In Fig 1, we showed the Wright item-person maps of the revised version of the NEI VFQ-25 (only items related to visual function). The separation index for person measures was 2.17, with reliability of 0.83. We also reported the psychometric properties of the socioemotional component of the NEI VFQ-25 (Table 5).

Table 4. Fit Statistics from Rasch Analysis with respective Items and Subscales using the only item related to visual function of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25).

Questions Items Subscales Measure Infit MNSQ Outfit MNSQ
Q2 General vision General vision 0.04 1.01 1.25
Q6 Seeing well up close Near vision 0.03 1.03 0.96
Q7 Finding objects on crowded shelf Near vision -0.01 0.92 0.80
Q9 Going downstairs at night Distance vision 0.00 0.98 0.88
Q10 Seeing objects off to side Peripheral vision -0.01 0.77 0.68
Q12 Matching clothes Color vision -0.04 0.97 0.92
Q13 Visiting others Social function -0.03 1.29 0.93
Q18 Limited endurance Role Limitations 0.02 1.28 1.15

MNSQ: mean square

Table 5. Rasch Analysis Fit Statistics of the Visual Function and Socioemotional Components from the National Eye Institute Visual Function Questionnaire (NEI VFQ 25).

Components Visual Function Socioemotional
Items in
Scale
(n)
8 8
Misfitting Items (n) None None
Person
Separation
Index
2.17 1.89
Person Separation Reliability (logits) 0.83 0.78
Mean Person Measure (logits) 0.05 0.02
Final variance of Principal Component (%) 61.20 60.8

Fig 1. Wright item-person maps related to visual function of the revised version of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25).

Fig 1

The left-hand column locates the person ability measures along the variable. The right-hand column locates the item difficulty measures along the variable.

We also investigated the association between demographic and clinical variables with the final scores of the revised version of the NEI VFQ-25. Within the clinical and demographic variables, there was a statistical relationship with the Rasch-calibrated scores in NEI VFQ-25 for the following variables in univariable models: visual acuity in the better eye (P<0.001), visual acuity in the worse eye (P<0.001), patients with low vision (P<0.001), gender (P<0.001), marital status (P = 0.001), employment status (P = 0.019), education level (P<0.001) and comorbidity index (P = 0.003). In a multivariable analysis, only 2 variables remained statistically significant: visual acuity in the better eye (P<0.001) and education level (P = 0.002) (S1 Table).

Discussion

In the current study, we investigated the psychometric properties of the Brazilian Portuguese version of the NEI VFQ-25 using Rasch analysis. Our results showed that the NEI VFQ-25 does not seem to be an unidimensional instrument; that is, it does not measure a single latent construct (quality of life related to visual function).[11] Although most items on the NEI VFQ-25 tap the construct of visual functioning, our results indicated that other items belonged to a different construct, namely socio-emotional component, corroborating findings from previous studies.[12, 13]

Unidimensionality of an instrument can be assessed by examining the fit statistics and principal component analysis of the residuals. Ideally items should have MNSQ values between 0.7 and 1.3. Items with MNSQ lower than 0.7 suggest a high level of predictability in the responses, indicating redundancy, [24] whereas values higher than 1.3 show an unacceptable level of noise in the responses. In total, seven items (Q1, Q3, Q4, Q11, Q17, Q19 and Q25) were found to misfit. Those items belonged to the subscales of general health, social function, mental health, ocular pain and role limitations

In addition to that, we also need to exam the principal component analysis of the residuals as a second test for unidimensionality. A high level of variance accounted for by the principal component leads to a low likelihood of additional components; a variance of 60% or greater is considered good. In the current study, the principal component analysis of the residuals showed that the variance explained by the principal component was 55.5%. Moreover, the unexplained variance explained by the first contrast was 2.81 eigenvalue units. The first contrast in the residuals reports whether there are patterns within variance that are unexplained by the principal component, which suggests a second construct is being measured.[13] According to previous studies, the current study applied the criterion that the contrast should have an eigenvalue higher than 2.0 to be considered evidence of a second construct because this would be greater than the magnitude seen with random data. Thus, our analysis showing the first contrast with a 2.81 eigenvalue units, suggests that the Brazilian Portuguese version of the NEI VFQ-25 was not unidimensional.

The loading of items onto the contrasts allows identification of which items tap different constructs. In our analysis, eight items loaded positively onto the first contrast with a correlation higher than 0.4. These items belonged to the following subscales: near vision (Q5), distance vision (Q8 and Q14), mental health (Q21and Q22) and dependency (Q20, Q23 and Q24),. This suggests that these eight items cannot be grouped with other items in the scale to measure a single latent construct, such as QoL related to visual function.

We were able to isolate items from the NEI VFQ-25, related only to a visual function component, after excluding items that were considered misfitted and also those items with high loadings on the principal component analysis of the residuals. When we re-examined the fit statistics of this revised version of the NEI VFQ-25, two items still presented infit and outfit values higher than 1.3 (Q1 and Q3). After excluding those items, new analysis was performed and no items were misfitted (Table 4). Moreover, the final variance of the principal component was 61.2% and the unexplained variance by the first contrast was 1.49 eingenvalue units (Table 5). These results suggest that this revised version of the NEI VFQ-25 showed no evidence of multidimensionality.

Simao et al used a “Factor analysis” and concluded that almost all subscales of NEI VFQ-25 belong to the same underlying dimension. However, careful analysis of their data suggests some evidence of multidimensionality.[16] For example, they showed that most of the subscales from the Portuguese version of the NEI VFQ-25 were influenced by central vision correlated with the first factor, while the “General vision”, “Ocular pain” and “Peripheral vision” subscales were included in a second factor.[16] We were able to find a second construct more related to a socio-emotional component formed by subscales such as: “General health”, “mental health”, “role limitations” and “dependency”, in contrast to central and peripheral vision constructs as highlighted in the previous study. This difference might be due to application of different types of analysis (Rasch as opposed to Factor Analysis). When evaluating an instrument with the Rasch model, more fundamental evidence may be provided to justify the use of scale scores on an interval level. Distances on the scales developed by the Factor Analysis approach are interpreted as equal over the full range of the scale.[31] The scale is treated as an interval scale based on ordinal level item scoring. In fact, Pesudovs et al investigated the psychometric properties of the NEI VFQ-25 with Rasch analysis in a group of patients with cataract and found that several subscales were not psychometrically sound. They concluded that the NEI VFQ-25 as an overall measure was flawed by multidimensionality.[13]

Marella et al performed a similar investigation with a group of low vision patients and found that the NEI VFQ-25 is a better performing instrument when divided into two different scales, corroborating the findings of our study. [12] In their study, 3 items were misfit (general health, pain around eyes, driving in difficult conditions) with infit mean scores higher than 1.3. The principal component analysis of the item residuals revealed that eight items loaded (correlation higher than 0.4) positively onto the first contrast and belonged to dependency (three items), mental health (three items), and role limitations (two items) subscales.

Another important characteristic of a good instrument is that items function similarly for persons at the same level of ability. Differential item functioning was tested for the following variables: age, sex, race, job status, marital status, education, level of income, low vision and type of eye disease (cataract, glaucoma and AMD). Differential item functioning occurs when subgroups of people with comparable levels of ability respond differently to an item, which implies a response to some characteristic other than item difficulty. We were not able to find evidence of differential item functioning for any of the variables mentioned. Thus, our results suggest that items from the Portuguese version of the NEI VFQ-25 could be interpreted similarly across subgroups of the sample, including different eye diseases, such as cataract, glaucoma and AMD.

We found that worse visual acuity and patients with lower education level had lower Rasch-calibrated NEI VFQ-25 scores. Even though patients with AMD had lower Rasch-calibrated scores of NEI VFQ-25 compared to cataract and glaucoma patients, when adjusting for visual acuity, the correlation with different types of eye disease in the multivariable analysis was not statistically significant, implying that visual acuity may be a better predictor for vision related QoL in comparison to the underlying cause of the vision loss. In fact, associations between worse visual acuity and QoL have already been demonstrated.[7, 32] Moreover, previous work have suggested that poor educated patients might have higher levels of emotional distress (including depression, anxiety, and anger) and physical distress (including aches and pains and malaise), which could influence the responses of the QoL questionnaire.[33]

The current study has limitations. Even though Rasch analysis is becoming the gold standard for scoring patient-reported outcome measures in ophthalmology, a multilevel model that allows simultaneous analysis of different dimensions in a multidimensional instrument could also be used.[8, 10, 34] Our sample consisted of patients with cataract, glaucoma and AMD. Thus, future studies should investigate psychometric validity of the Rasch calibrated version of the NEI VFQ-25 in a sample with more varied range of eye diseases.

Conclusion

Our findings indicate that the Brazilian Portuguese version of the NEI VFQ-25 is not psychometrically optimal for assessing QoL related only to visual function. Rather, we found a second trait, described as a socioemotional component from results of the Rasch analysis. Thus, in order to obtain psychometrically valid constructs, both components with their respective subscales and items (visual functioning and socioemotional) should be analyzed separately. Future studies in Brazil including patients with different eye diseases are needed to substantiate our findings and evaluate the sensitivity of this calibrated version of the NEI VFQ-25.

Supporting information

S1 Fig. Item fit statistics for the National Eye Institute Visual Function Questionnaire-25.

(PNG)

S2 Fig. Principal component analysis of the residuals.

(PNG)

S3 Fig. Corresponding loadings for the first contrast.

(PNG)

S4 Fig. Item fit statistics for revised version of the National Eye Institute Visual Function Questionnaire-25.

(PNG)

S1 Table. Univariate and Multivariate regression analysis between demographic and clinical variables and final scores of the revised version of the National Eye Institute Visual Function Questionnaire-25.

(XLSX)

Data Availability

We have no ethical or legal restrictions on sharing our data set and we have made it available within the Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Social science & medicine (1982). 1995;41(10):1403–9. Epub 1995/11/01. 10.1016/0277-9536(95)00112-k . [DOI] [PubMed] [Google Scholar]
  • 2.Khanna D, Tsevat J. Health-related quality of life—an introduction. The American journal of managed care. 2007;13 Suppl 9:S218–23. Epub 2008/01/12. . [PubMed] [Google Scholar]
  • 3.Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998;116(11):1496–504. Epub 1998/11/21. 10.1001/archopht.116.11.1496 . [DOI] [PubMed] [Google Scholar]
  • 4.Suzukamo Y, Oshika T, Yuzawa M, Tokuda Y, Tomidokoro A, Oki K, et al. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health and Quality of Life Outcomes. 2005;3:65–. 10.1186/1477-7525-3-65 PMC1283746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Romero M, Vivas-Consuelo D, Alvis-Guzman N. Is Health Related Quality of Life (HRQoL) a valid indicator for health systems evaluation? SpringerPlus. 2013;2(1):664 10.1186/2193-1801-2-664 PMC3866375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Karimi M, Brazier J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? PharmacoEconomics. 2016;34(7):645–9. Epub 2016/02/20. 10.1007/s40273-016-0389-9 . [DOI] [PubMed] [Google Scholar]
  • 7.Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050–8. 10.1001/archopht.119.7.1050 . [DOI] [PubMed] [Google Scholar]
  • 8.Medeiros FA, Gracitelli CP, Boer ER, Weinreb RN, Zangwill LM, Rosen PN. Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology. 2015;122(2):293–301. Epub 2014/12/03. 10.1016/j.ophtha.2014.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gracitelli CP, Abe RY, Tatham AJ, Rosen PN, Zangwill LM, Boer ER, et al. Association Between Progressive Retinal Nerve Fiber Layer Loss and Longitudinal Change in Quality of Life in Glaucoma. JAMA Ophthalmol. 2015. Epub 2015/01/09. 10.1001/jamaophthalmol.2014.5319 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Diniz-Filho A, Abe RY, Cho HJ, Baig S, Gracitelli CP, Medeiros FA. Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma. Ophthalmology. 2016;123(4):754–9. Epub 2016/02/28. 10.1016/j.ophtha.2015.12.014 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Massof RW, Fletcher DC. Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res. 2001;41(3):397–413. 10.1016/s0042-6989(00)00249-2 . [DOI] [PubMed] [Google Scholar]
  • 12.Marella M, Pesudovs K, Keeffe JE, O'Connor PM, Rees G, Lamoureux EL. The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci. 2010;51(6):2878–84. 10.1167/iovs.09-4494 . [DOI] [PubMed] [Google Scholar]
  • 13.Pesudovs K, Gothwal VK, Wright T, Lamoureux EL. Remediating serious flaws in the National Eye Institute Visual Function Questionnaire. J Cataract Refract Surg. 2010;36(5):718–32. 10.1016/j.jcrs.2009.11.019 . [DOI] [PubMed] [Google Scholar]
  • 14.Andrich D. Rating scales and Rasch measurement. Expert Rev Pharmacoecon Outcomes Res. 2011;11(5):571–85. 10.1586/erp.11.59 . [DOI] [PubMed] [Google Scholar]
  • 15.Dougherty BE, Bullimore MA. Comparison of scoring approaches for the NEI VFQ-25 in low vision. Optom Vis Sci. 2010;87(8):543–8. 10.1097/OPX.0b013e3181e61bd8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Simao LM, Lana-Peixoto MA, Araujo CR, Moreira MA, Teixeira AL. The Brazilian version of the 25-Item National Eye Institute Visual Function Questionnaire: translation, reliability and validity. Arq Bras Oftalmol. 2008;71(4):540–6. Epub 2008/09/18. 10.1590/s0004-27492008000400014 . [DOI] [PubMed] [Google Scholar]
  • 17.Bradley C, Massof RW. Validating Translations of Rating Scale Questionnaires Using Rasch Analysis. Ophthalmic Epidemiol. 2017;24(1):1–2. Epub 2017/01/14. 10.1080/09286586.2016.1246667 . [DOI] [PubMed] [Google Scholar]
  • 18.Chylack LT Jr., Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111(6):831–6. Epub 1993/06/01. 10.1001/archopht.1993.01090060119035 . [DOI] [PubMed] [Google Scholar]
  • 19.Seddon JM, Sharma S, Adelman RA. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology. 2006;113(2):260–6. Epub 2006/02/07. 10.1016/j.ophtha.2005.11.001 . [DOI] [PubMed] [Google Scholar]
  • 20.Coleman HR, Chan CC, Ferris FL 3rd, Chew EY. Age-related macular degeneration. Lancet. 2008;372(9652):1835–45. Epub 2008/11/26. 10.1016/S0140-6736(08)61759-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Boone W. Understanding Person Measures In: Boone W, Staver J, Yeale M, editors. Rasch Analysis in the Human Sciences. New York: Springer; 2014. p. 69–92. [Google Scholar]
  • 22.Bond TG, Fox CM. Applying the Rasch Model. Fundamental Measurement in the Human Sciences. 2nd Edition ed2007. 29–48 p. [Google Scholar]
  • 23.Peters D, Heijl A, Brenner L, Bengtsson B. Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up. Acta Ophthalmol. 2015;93(8):745–52. Epub 2015/09/19. 10.1111/aos.12839 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wright BD LJ, Gustafson JE, Martin-Lof P. Reasonable mean-square fit values. 1994;8(3):370. [Google Scholar]
  • 25.Smith EVJ. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas. 2002;3:205–31. [PubMed] [Google Scholar]
  • 26.Wright BD, Douglas GA. Best test design and selftailored testing Research Memorandum. Chicago: Statistical Laboratory, Department of Education, University of Chicago; 1975. [Google Scholar]
  • 27.Globe DR, Varma R, Torres M, Wu J, Klein R, Azen SP. Self-reported comorbidities and visual function in a population-based study: the Los Angeles Latino Eye Study. Arch Ophthalmol. 2005;123(6):815–21. Epub 2005/06/16. 10.1001/archopht.123.6.815 . [DOI] [PubMed] [Google Scholar]
  • 28.Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236–40. Epub 2006/03/01. 10.1167/iovs.05-0981 . [DOI] [PubMed] [Google Scholar]
  • 29.Smith AB, Wright EP, Rush R, Stark DP, Velikova G, Selby PJ. Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale. Psycho-oncology. 2006;15(9):817–27. Epub 2005/12/15. 10.1002/pon.1015 . [DOI] [PubMed] [Google Scholar]
  • 30.Chien T-W, Wang W-C, Wang H-Y, Lin H-J. Online assessment of patients' views on hospital performances using Rasch model's KIDMAP diagram. BMC Health Services Research. 2009;9:135–. 10.1186/1472-6963-9-135 PMC2727503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Prieto L, Alonso J, Lamarca R. Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health and Quality of Life Outcomes. 2003;1:27–. 10.1186/1477-7525-1-27 PMC194220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hirneiss C. The impact of a better-seeing eye and a worse-seeing eye on vision-related quality of life. Clin Ophthalmol. 2014;8:1703–9. Epub 2014/09/13. 10.2147/OPTH.S64200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ross CE, Van Willigen M. Education and the Subjective Quality of Life. Journal of Health and Social Behavior. 1997;38(3):275–97. 10.2307/2955371 [DOI] [PubMed] [Google Scholar]
  • 34.Gorter R, Fox J-P, Twisk JWR. Why item response theory should be used for longitudinal questionnaire data analysis in medical research. BMC Medical Research Methodology. 2015;15:55 10.1186/s12874-015-0050-x PMC4520067. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Stefan Hoefer

12 Sep 2019

PONE-D-19-19847

Psychometric Properties of the Portuguese Version of the National Eye Institute Visual Function Questionnaire-25

PLOS ONE

Dear Dr. Abe,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that fully addresses all the points raised during the review process in a concise manner.

We would appreciate receiving your revised manuscript by Oct 27 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Stefan Hoefer

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: No

  1. Please provide an amended Funding Statement that declares *all* the funding or sources of support received during this specific study (whether external or internal to your organization) as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  

  1. Please state what role the funders took in the study.  If any authors received a salary from any of your funders, please state which authors and which funder. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. We noticed you have some minor occurrence of overlapping text in the Discussion with the following previous publication(s), which needs to be addressed:

Prieto, Luis, Jordi Alonso, and Rosa Lamarca. "Classical test theory versus Rasch analysis for quality of life questionnaire reduction." Health and Quality of Life Outcomes 1.1 (2003): 27.

Pesudovs, Konrad, et al. "Remediating serious flaws in the National eye Institute visual function questionnaire." Journal of Cataract & Refractive Surgery 36.5 (2010): 718-732.

The text that needs to be addressed occurs in the third paragraph of the Discussion and begins, "A high level of variance accounted for..." and in the two sentences beginning, "When evaluating an instrument with the Rasch model..."

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors investigate the psychometric properties of the Brazilian Portuguese version of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in a group of patients with different eye diseases. This is an important topic, as no study has yet applied Rasch Analysis to the Brazilian Portuguese version of the NEI VFQ-25. The study is well designed, executed and reported.

However, I have a few comments.

1. Material and Methods: Adding some subheading could improve flow and readability for the reader.

2. Not all readers are familiar with the NEI VFQ-25. Could you please provide more information about the NEI VFQ-25 (how initially developed, how many response options, which scaling [Likert scaling?], subscales)?

3. Targeting: Did you inspect the person-item map and calculated the difference between item and person means before revising the questionnaire? Knowing if the difficulty of the items adequately targets the ability of the sample provides valuable information.

4. Figure 2: The mean person achievement measure is much lower than the mean item difficulty, suggesting a lack of items at the low-ability end. Could you please explain and describe that? This finding is completely counter-intuitive as most questionnaires struggle with items that are too easy, in particular in questionnaires trying to capture VRQOL.

5. Table 2: Does the SAP MD values only refer to glaucoma patients or to the overall sample?

6. Could you pleaes add more information on visual ability of the participants? Please report n/% of the sample in the categories none/mild/moderate/severe visual impairment.

7. Line 252: The authors say, that four items were found to misfit with Infit and/or Outfit MNSQ values <0.7 or >1.3. In Table 3 Infit and Outfit MNSQ values for Q24 are within these values, so why was this item found to misfit? Same for Q25.

8. Line 226: The authors say, that they investigated the relationship between final Rasch-calibrated NEI VFQ-25 scores with socioeconomic variables using a linear regression model. Could you please provide the results in a table in the supplement to see raw and adjusted effects?

9. Most of the readers might not be familiar with Rasch analysis, so please explain in more detail the factor analysis/factor loading you used to assess unidimensionality of the scale. Otherwise it might not be easy to follow why items Q1, Q3, Q21, Q22, Q17, A18, Q20 and Q 23 were excluded?

10. Please cite additional literature which also reports the NEI-VFQ to be multi-dimensional.

11. Line 39: Typing error/ double word: “National Eye Institute Visual Questionnaire (NEI VFQ-25) questionnaire”

Reviewer #2: The purpose of this manuscript is to investigate the psychometric properties of the Brazilian Portuguese version of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) questionnaire in a group of patients with different eye diseases by Rasch analysis. However, The authers found that Portuguese version of the NEI VFQ-25 is not a unidimensional instrument in measuring psychometric properties. Although they suggest that analyzing both visual function and socio-emotional components separately may be a valid method, they did not test the validity of this method. In addition, some mistakes in grammar was found in the manuscript.

Reviewer #3: In this paper, Abe et al. investigated the psychometric properties of the Brazilian Portuguese version of the National Eye Institute Visual Function Questionnaire-25. They found the Portuguese version of NEI VFQ-25 is not a unidimensional instrument, and suggested the visual functioning and socio-emotional components should be analyzed separately. In general, the paper is well written and in a good quality. The study is well designed, the data are convincing, the analysis is cogent.

Specific comments follow:

1. In the methods part, the author may want to elaborate how the NEI VFQ-25 questionnaires were conducted. Were they self-administered or interviewer-administered?

2. In the methods part (line 206), “Socio-economic questionnaires were also administered along with the NEI VFQ-25 to all patients.” A sample of this questionnaire should be attached to this manuscript, preferably as supplementary materials.

3. In the results part (line 252), “Four items (Q4, Q19, Q24 and Q25) were found to misfit (from subscales: general health, mental health, ocular pain and role limitations) with infit and/or outfit mean scores >1.3.”. However, from Table 3, the infit MNSQ and outfit MNSQ of Q24 are 0.96 and 0.87 respectively, and are both less than 1.3.

4. As authors wrote in the intro (line 110-115), “Marella and colleagues have suggested that the NEI VFQ-25 questionnaire does not seem to be unidimensional, and that the questionnaire items may actually be measuring two different underlying constructs, one related to visual functioning and another to socio-emotional status.” It would be necessary for the authors to include the comparison between the findings from the present study with Marella et al.’s result.

5. It is surprising to see that the items authors found misfitting in this study (namely Q4, Q19, Q24 and Q25) were very much different from the misfitting questions Pesudovs et al. found in their study (PMID: 20457362). Authors need to provide explanations for this difference.

Reviewer #4: This is an interesting finding. The authors investigated the psychometric properties of NEI VFQ-25 using Rasch analysis in a population of Brazilian patients with a variety of eye diseases. They found that the Brazilian Portuguese version of the NEI VFQ-25 is not psychometrically optimal for assessing QoL related only to visual function. Moreover, they also observed a second trait, described as a socioemotional component from results of the Rasch analysis. Overall, the authors have described the experimental design and knowledge gaps to be generally filled with this study. The results have been generally presented in a reasonable and expected approach with solid statistical analysis.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Hongbing Zhang

Reviewer #3: No

Reviewer #4: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-19-19847_reviewer.pdf

PLoS One. 2019 Dec 10;14(12):e0226086. doi: 10.1371/journal.pone.0226086.r002

Author response to Decision Letter 0


29 Sep 2019

We have addressed all comments and suggestions made by reviewers. Details are available in the point-by-point letter response attached.

Attachment

Submitted filename: Point by Point - Plos ONE - 09.29.2019.docx

Decision Letter 1

Stefan Hoefer

1 Nov 2019

PONE-D-19-19847R1

Psychometric Properties of the Portuguese Version of the National Eye Institute Visual Function Questionnaire-25

PLOS ONE

Dear Dr. Abe,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Dec 16 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Stefan Hoefer

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

I have read the revised version of the manuscript myself and believe you have addressed most of the comments of the previews review well. New comments regarding the revised version have been raised. Please try to respond by either commenting or correcting in the manuscript the issues discussed by the reviewer.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

Reviewer #5: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: In the revised manusscript, the authors mentioned that three items were found to misfit according to Rasch analysis and mental health was cancelled, the reason should be addressed. Secondly, nine items

Instead of eight ones loaded positively onto the first contrast with a correlation higher than 0.4 in the revised manuscript, why?. Thirdly, they did not test the validity of both visual function and socio-emotional components separately. Finally, some results in revised manuscript is different from the first ones, does it means that the consistency of psychometric properties of the Brazilian Portuguese version of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) questionnaire in a group of patients with different eye diseases by Rasch analysis is not same?

Reviewer #3: Thank you for putting significant effort into this revision. While the paper still has some weaknesses, you have substantively addressed each of my comments. I don't have futher questions.

Reviewer #4: (No Response)

Reviewer #5: The authors investigate the psychometric properties of the Brazilian Portuguese version of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in a group of patients with different eye diseases. This is an important topic, as no study has yet applied Rasch Analysis to the Brazilian Portuguese Version of the NEI VFQ-25. The authors have adressed all comments, so I have no furhter remarks.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

Reviewer #5: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-19-19847_R1 (1).pdf

PLoS One. 2019 Dec 10;14(12):e0226086. doi: 10.1371/journal.pone.0226086.r004

Author response to Decision Letter 1


16 Nov 2019

We have addressed all comments and suggestions made by reviewers. Details are available in the point-by-point letter response attached.

Attachment

Submitted filename: Point by Point - Plos ONE - November 2019.docx

Decision Letter 2

Stefan Hoefer

20 Nov 2019

Psychometric Properties of the Portuguese Version of the National Eye Institute Visual Function Questionnaire-25

PONE-D-19-19847R2

Dear Dr. Abe,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Stefan Hoefer

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Stefan Hoefer

2 Dec 2019

PONE-D-19-19847R2

Psychometric Properties of the Portuguese Version of the National Eye Institute Visual Function Questionnaire-25

Dear Dr. Abe:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Stefan Hoefer

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Item fit statistics for the National Eye Institute Visual Function Questionnaire-25.

    (PNG)

    S2 Fig. Principal component analysis of the residuals.

    (PNG)

    S3 Fig. Corresponding loadings for the first contrast.

    (PNG)

    S4 Fig. Item fit statistics for revised version of the National Eye Institute Visual Function Questionnaire-25.

    (PNG)

    S1 Table. Univariate and Multivariate regression analysis between demographic and clinical variables and final scores of the revised version of the National Eye Institute Visual Function Questionnaire-25.

    (XLSX)

    Attachment

    Submitted filename: PONE-D-19-19847_reviewer.pdf

    Attachment

    Submitted filename: Point by Point - Plos ONE - 09.29.2019.docx

    Attachment

    Submitted filename: PONE-D-19-19847_R1 (1).pdf

    Attachment

    Submitted filename: Point by Point - Plos ONE - November 2019.docx

    Data Availability Statement

    We have no ethical or legal restrictions on sharing our data set and we have made it available within the Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES